Join

Compare · BOWN vs HLN

BOWN vs HLN

Side-by-side comparison of Bowen Acquisition Corp (BOWN) and Haleon plc (HLN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BOWN and HLN operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
  • HLN carries a market cap of $39.59B.
  • Over the past year, BOWN is down 10.0% and HLN is down 18.3% - BOWN leads by 8.3 points.
  • HLN has hit the wire 11 times in the past 4 weeks while BOWN has been quiet.
  • HLN has more recent analyst coverage (19 ratings vs 0 for BOWN).
PerformanceBOWN-10.00%HLN-18.59%
2025-06-09+0.00%2026-06-04
MetricBOWNHLN
Company
Bowen Acquisition Corp
Haleon plc
Price
$9.99+15.49%
$8.89-2.41%
Market cap
-
$39.59B
1M return
+0.00%
-4.46%
1Y return
-10.00%
-18.25%
Industry
Package Goods/Cosmetics
Package Goods/Cosmetics
Exchange
NASDAQ
NYSE
IPO
2023
2022
News (4w)
0
11
Recent ratings
0
19
HLN

Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.